Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

59
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
59
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

547
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
547

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal mapping of a randomized controlled trial of EEG neurofeedback in PTSD: Early symptom stabilization and implications for adjunctive therapeutic potential.

Psychiatry research. Neuroimaging·2026
Same author

Test-Retest Reliability of Standardized Diagnostic Interviews for Common Adult Psychiatric Disorders: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same author

Confounding and Circularity in Actigraphy Prediction-Reply.

JAMA psychiatry·2026
Same author

Informing Equity-Oriented Approaches to Postpartum Care Following Severe Maternal Morbidity Events: A Qualitative Descriptive Study Protocol.

Global qualitative nursing research·2026
Same author

Developing a core outcome set for generalized anxiety disorder during the perinatal period: Identifying core treatment outcomes in perinatal anxiety.

The British journal of clinical psychology·2026
Same author

Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortium.

medRxiv : the preprint server for health sciences·2026
Same journal

Notice of Retraction. Ren Y, et al. Personality Traits and Social Isolation in Older Adults. JAMA Netw Open. 2026;9(5):e269569.

JAMA network open·2026
Same journal

Error in Grant Number in Funding/Support Section.

JAMA network open·2026
Same journal

The Supplementary Role of Friends in Caregiving Networks.

JAMA network open·2026
Same journal

Urbanicity, Neighborhood Conditions, and Dementia Mortality.

JAMA network open·2026
Same journal

Equity and Cancer Survival Among Veterans Health Administration Patients: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same journal

Limbic System Microstructure in Neonates With Antenatal Opioid Exposure.

JAMA network open·2026
See all related articles

Related Experiment Video

Updated: Jul 15, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.7K

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication.

Benjamin Schwartzmann1, Prabhjot Dhami1,2,3, Rudolf Uher4

  • 1eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser University, Surrey, British Columbia, Canada.

JAMA Network Open
|September 28, 2023
PubMed
Summary
This summary is machine-generated.

This study developed an electroencephalography (EEG) model to predict depression treatment response. The EEG model showed promising accuracy in predicting response to selective serotonin reuptake inhibitor (SSRI) medications.

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

326

Related Experiment Videos

Last Updated: Jul 15, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

326

Area of Science:

  • Neuroscience
  • Psychiatry
  • Computational Biology

Background:

  • Untreated depression poses a significant public health challenge.
  • Predicting effective antidepressant treatment remains difficult, often involving trial-and-error.
  • Personalized medicine approaches are needed to improve depression treatment outcomes.

Purpose of the Study:

  • To develop and validate a predictive model for antidepressant treatment response using electroencephalography (EEG) data.
  • To assess the model's ability to predict response to two distinct selective serotonin reuptake inhibitor (SSRI) medications.
  • To investigate the utility of EEG biomarkers for personalized depression treatment.

Main Methods:

  • A prognostic study utilizing EEG data from two independent cohorts (CAN-BIND and EMBARC) of individuals with major depressive disorder.
  • Development of a predictive model based on EEG features.
  • Internal validation using the CAN-BIND cohort and external validation using the EMBARC cohort.
  • Treatment response defined as a ≥50% reduction in depression severity at 8 weeks.

Main Results:

  • The EEG-based model achieved balanced accuracies of 64.2% (internal validation) and 63.7% (external validation) in predicting SSRI treatment response.
  • Sensitivity and specificity metrics indicated the model's potential in identifying responders.
  • Performance in the EMBARC placebo group (balanced accuracy 48.7%) suggested the model's specificity for SSRI treatment response.

Conclusions:

  • An EEG-based predictive model demonstrates potential for forecasting antidepressant treatment response.
  • The validated model offers a promising tool for personalized depression management.
  • Further research can refine EEG biomarkers for more precise prediction of treatment outcomes.